Lokivetmab

180 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

180

Total Reports

Deaths Reported

560.0%

Death Rate

Active Ingredients

Lokivetmab

Administration Routes

UnknownSubcutaneousParenteralOralSubconjunctival

Species Affected

Dog 180

Most Affected Breeds

Retriever - Labrador 17

Shih Tzu 11

Terrier - Yorkshire 9

American Pit Bull Terrier 9

Chihuahua 8

Maltese 8

Pit Bull 7

Beagle 6

Bulldog - French 6

Shepherd Dog - German 5

Most Reported Reactions

Lack of efficacy - NOS 26

Vomiting 19

Decreased appetite 16

Lethargy (see also Central nervous system depression in Neurological) 15

Elevated serum alkaline phosphatase (SAP) 13

Diarrhoea 13

Elevated alanine aminotransferase (ALT) 11

Lethargy (see also Central nervous system depression in 'Neurological') 11

Pain NOS 9

Inappropriate urination 9

Abnormal adrenocorticotropic hormone (ACTH) stimulation test 9

Proteinuria 8

Outcome Breakdown

Outcome Unknown

97 (53.6%)

Recovered/Normal

44 (24.3%)

Ongoing

25 (13.8%)

Euthanized

8 (4.4%)

Recovered with Sequela

5 (2.8%)

Died

2 (1.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.